Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 5 - Frontiers in Clinical Drug Research - Anti-Cancer Agents
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By BENTHAM SCIENCE PUBLISHERS

9789811405150

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Subject Index

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 5 - Frontiers in Clinical Drug Research - Anti-Cancer Agents ◽

10.2174/9789811405150119050009 ◽

2019 ◽

pp. 166-174

Generations of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Battle against Drug Resistant Lung Cancer

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 5 - Frontiers in Clinical Drug Research - Anti-Cancer Agents ◽

10.2174/9789811405150119050008 ◽

2019 ◽

pp. 122-165

Author(s):

Kenneth K.W. To ◽

Wing-Sum Tong

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Receptor Tyrosine Kinase Inhibitors

Second-Generation Protein Kinase Inhibitor - A Focus on Quizartinib, A Promising Targeted Therapy for High-Risk FLT3+ Patients with Acute Myeloid Leukemia

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 5 - Frontiers in Clinical Drug Research - Anti-Cancer Agents ◽

10.2174/9789811405150119050003 ◽

2019 ◽

pp. 1-21

Author(s):

Xavier Thomas ◽

Etienne Paubelle

Keyword(s):

Acute Myeloid Leukemia ◽

Targeted Therapy ◽

High Risk ◽

Protein Kinase ◽

Myeloid Leukemia ◽

Second Generation ◽

Kinase Inhibitor ◽

Protein Kinase Inhibitor ◽

Acute Myeloid

Ros-Mediated Induction of Apoptosis in Breast Cancer Cells

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 5 - Frontiers in Clinical Drug Research - Anti-Cancer Agents ◽

10.2174/9789811405150119050007 ◽

2019 ◽

pp. 113-121

Author(s):

Işıl Yıldırım

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Induction Of Apoptosis

Cancer Immune Evasion in Gastrointestinal Cancer: Can this be Overcome by Combination of Histone Deacetylase and Immune Checkpoint Inhibitors?

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 5 - Frontiers in Clinical Drug Research - Anti-Cancer Agents ◽

10.2174/9789811405150119050005 ◽

2019 ◽

pp. 50-84

Author(s):

Yuequan Shi ◽

Onyinyechi Duru ◽

Zifang Zou ◽

David Kerr

Keyword(s):

Histone Deacetylase ◽

Immune Evasion ◽

Gastrointestinal Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors

Preface

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 5 - Frontiers in Clinical Drug Research - Anti-Cancer Agents ◽

10.2174/9789811405150119050001 ◽

2019 ◽

pp. i-i

Long Non-Coding RNAs in Cancer Progression: Implication for Anti-Cancer Therapy

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 5 - Frontiers in Clinical Drug Research - Anti-Cancer Agents ◽

10.2174/9789811405150119050006 ◽

2019 ◽

pp. 85-112

Author(s):

Chang Gong ◽

Zihao Liu ◽

Andrew J. Sanders ◽

Wen G. Jiang

Keyword(s):

Cancer Therapy ◽

Cancer Progression ◽

Anti Cancer ◽

Non Coding Rnas

Physical Exercise for Cancer Patients Treated with Chemotherapy

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 5 - Frontiers in Clinical Drug Research - Anti-Cancer Agents ◽

10.2174/9789811405150119050004 ◽

2019 ◽

pp. 22-49

Author(s):

Shinichiro Morishita ◽

Atsuhiro Tsubaki ◽

Jack B. Fu

Keyword(s):

Physical Exercise ◽

Cancer Patients

List of Contributors

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 5 - Frontiers in Clinical Drug Research - Anti-Cancer Agents ◽

10.2174/9789811405150119050002 ◽

2019 ◽

pp. ii-ii

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 5 - Frontiers in Clinical Drug Research - Anti-Cancer AgentsLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By BENTHAM SCIENCE PUBLISHERS

Subject Index

Generations of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Battle against Drug Resistant Lung Cancer

Second-Generation Protein Kinase Inhibitor - A Focus on Quizartinib, A Promising Targeted Therapy for High-Risk FLT3+ Patients with Acute Myeloid Leukemia

Ros-Mediated Induction of Apoptosis in Breast Cancer Cells

Cancer Immune Evasion in Gastrointestinal Cancer: Can this be Overcome by Combination of Histone Deacetylase and Immune Checkpoint Inhibitors?

Preface

Long Non-Coding RNAs in Cancer Progression: Implication for Anti-Cancer Therapy

Physical Exercise for Cancer Patients Treated with Chemotherapy

List of Contributors

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 5 - Frontiers in Clinical Drug Research - Anti-Cancer Agents
Latest Publications